Treatment‐driven peripheral blood transcriptomic remodelling and baseline predictors of ESSDAI and STAR response to B‐cell therapy in Sjögren's disease

Study limitation reported by the research below: “Differential expression used unadjusted p-values (p<0.01), increasing the risk of false-positive findings in a small cohort of 43 participants.”